GITNUX MARKETDATA REPORT 2024

Weight Loss Drug Industry Statistics

The weight loss drug industry has experienced steady growth in recent years, driven by increasing obesity rates and a growing demand for effective weight management solutions.

Highlights: Weight Loss Drug Industry Statistics

  • The global weight loss market is projected to reach $424.8 billion by 2025.
  • The U.S. weight loss market saw a high of $78.4 billion in 2019.
  • In 2016, the global weight loss drug market was valued at about $3.85 billion.
  • By 2023, it is estimated that the weight loss drug market will reach about $4.09 billion.
  • Orlistat accounted for 30.5% of the global weight loss drug market in 2020.
  • Global obesity management market is expected to progress at an 8.4% CAGR from 2021 to 2028.
  • The Weight Loss and Obesity Management Market was $175.94 billion in 2019 and is expected to reach $303.81 billion by 2027.
  • The Asia-Pacific region is expected to register the fastest CAGR of 7.6% from 2020 to 2027 in the weight loss and obesity management market.
  • As of 2020, the U.S. contribution to the global weight loss and weight management market was 35%.
  • Approximately 17% of the global population used dietary supplements for weight loss in 2020.
  • The commercial weight loss programs segment is projected to hold a market share of 20.3% by 2027.
  • Anti-obesity drugs are expected to reach $2.8 billion by 2022 in the U.S.
  • The global weight loss and diet management market is predicted to reach $348.1 billion by 2026.
  • Europe held approximately 31.34% of the weight loss and weight management diet market share in 2019.
  • The weight loss supplement market is anticipated to grow at a CAGR of 4.9% from 2021 to 2028.
  • Prescription drugs segment held the largest market share of 74.5% in the weight loss products market in 2020.
  • The Asia Pacific weight management market is expected to witness a CAGR of 7.1% from 2021 to 2026.
  • The diet food and drink segment is expected to surge at the fastest CAGR of 8.3% from 2021 to 2028 in the weight loss and weight management market.
  • Over 25% of the global adult population was overweight in 2019.
  • The weight loss and weight management market growth in Latin America will likely have a CAGR of 6.8% from 2020 to 2027.

Table of Contents

The Latest Weight Loss Drug Industry Statistics Explained

The global weight loss market is projected to reach $424.8 billion by 2025.

The statistic indicates that the global weight loss market is predicted to grow substantially, reaching a total value of $424.8 billion by the year 2025. This projection suggests a high level of demand for weight loss products, services, and solutions worldwide. The growth of the weight loss market may be attributed to several factors, including increasing awareness of the importance of maintaining a healthy weight, rising obesity rates, and growing consumer interest in health and wellness. The significant market size forecasted for 2025 underscores the potential opportunities for businesses operating in the weight loss industry to capitalize on this trend and cater to the evolving needs and preferences of consumers seeking to achieve their weight loss goals.

The U.S. weight loss market saw a high of $78.4 billion in 2019.

The statistic “The U.S. weight loss market saw a high of $78.4 billion in 2019” indicates the total revenue generated within the weight loss industry in the United States during that year. This figure represents the amount of money consumers spent on various weight loss products, services, programs, and supplements. The high value of $78.4 billion suggests a significant demand for weight loss solutions in the U.S. market, driven by factors such as increasing awareness of health and wellness, societal pressure for achieving ideal body weight, and a growing focus on fitness and appearance. The statistic highlights the size and profitability of the weight loss industry, reflecting a lucrative market opportunity for businesses operating in this sector.

In 2016, the global weight loss drug market was valued at about $3.85 billion.

The statistic “In 2016, the global weight loss drug market was valued at about $3.85 billion” indicates the total monetary value of sales generated by weight loss drugs on a global scale during the year 2016. This figure represents the significant size and financial impact of the weight loss drug industry in that particular year. The value of $3.85 billion suggests a substantial demand for weight loss products and services, as well as the willingness of individuals worldwide to invest in solutions for managing weight and improving health. This statistic can be used by stakeholders such as pharmaceutical companies, healthcare providers, and researchers to understand the market dynamics, trends, and opportunities within the weight loss industry.

By 2023, it is estimated that the weight loss drug market will reach about $4.09 billion.

The statistic stating that the weight loss drug market is estimated to reach approximately $4.09 billion by 2023 indicates a significant growth trend in this industry. This projection suggests an increasing demand for weight loss medications, possibly driven by rising obesity rates and a growing focus on health and wellness. The market value of $4.09 billion highlights the economic significance of weight loss drugs as a lucrative sector within the pharmaceutical industry. Factors such as changing lifestyles, dietary habits, and healthcare trends could all contribute to the expected expansion of this market over the next few years.

Orlistat accounted for 30.5% of the global weight loss drug market in 2020.

The statistic “Orlistat accounted for 30.5% of the global weight loss drug market in 2020” means that out of all the sales of weight loss drugs worldwide in 2020, Orlistat, a specific weight loss medication, constituted 30.5% of the market share. This indicates that Orlistat was a significant player in the weight loss drug market during that year, capturing a substantial portion of sales compared to other weight loss medications. The statistic highlights Orlistat’s popularity, effectiveness, or market positioning in helping individuals manage their weight and underscores its importance in the competitive landscape of the global weight loss drug industry in 2020.

Global obesity management market is expected to progress at an 8.4% CAGR from 2021 to 2028.

This statistic indicates that the global obesity management market is projected to experience a Compound Annual Growth Rate (CAGR) of 8.4% from 2021 to 2028. A CAGR is a measure of the average annual growth rate over a specified period of time, providing a smooth rate of return that disregards fluctuations. In this context, the 8.4% CAGR suggests a steady and significant growth trajectory for the obesity management market over the next seven years. Factors such as increasing prevalence of obesity, rising awareness about health and wellness, advancements in medical technology, and a growing focus on preventive healthcare are likely to be driving forces behind this projected growth rate.

The Weight Loss and Obesity Management Market was $175.94 billion in 2019 and is expected to reach $303.81 billion by 2027.

The statistic indicates that the global Weight Loss and Obesity Management Market was valued at $175.94 billion in 2019 and is projected to grow to $303.81 billion by 2027. This substantial increase suggests a significant expansion in the market for products and services related to weight loss and obesity management over the upcoming years. The rising prevalence of obesity, a growing awareness of health and wellness, and an increasing focus on preventive healthcare are likely driving factors behind this market growth. This trend highlights the importance of addressing weight-related health issues and signifies opportunities for businesses and healthcare providers operating in this sector to meet the escalating demand for weight management solutions.

The Asia-Pacific region is expected to register the fastest CAGR of 7.6% from 2020 to 2027 in the weight loss and obesity management market.

This statistic implies that the Asia-Pacific region is projected to experience the highest Compound Annual Growth Rate (CAGR) of 7.6% in the weight loss and obesity management market between 2020 and 2027. This suggests a significant growth potential for companies operating in this market in the Asia-Pacific region, indicating a growing demand for products and services related to weight loss and obesity management. Factors driving this growth may include an increasing awareness of the importance of healthy lifestyles, rising disposable incomes, changing dietary habits, and a higher prevalence of obesity in the region. This statistic signals lucrative opportunities for businesses to expand and invest in the Asia-Pacific weight loss and obesity management market over the forecast period.

As of 2020, the U.S. contribution to the global weight loss and weight management market was 35%.

The statistic indicates that in the year 2020, the United States held a significant share of 35% in the global weight loss and weight management market. This means that out of the total revenue generated in this market worldwide, 35% of it was attributed to products, services, and technologies related to weight loss and weight management originating from the U.S. This figure highlights the influential role that the U.S. plays in the global weight management industry, potentially driven by factors such as high demand for weight loss solutions, advanced research and development in this field, as well as a strong presence of companies and professionals specializing in weight management within the country.

Approximately 17% of the global population used dietary supplements for weight loss in 2020.

The statistic stating that approximately 17% of the global population used dietary supplements for weight loss in 2020 indicates the prevalence of individuals worldwide who turned to supplements as a means to manage their weight. This implies a significant portion of the population sought out these products to aid in their weight loss efforts, reflecting a growing trend towards health and wellness consciousness. The use of dietary supplements for weight loss suggests a desire for additional support in achieving health and fitness goals beyond traditional diet and exercise practices. Understanding the extent to which individuals are utilizing such supplements can provide insights into evolving health trends and consumer behaviors on a global scale.

The commercial weight loss programs segment is projected to hold a market share of 20.3% by 2027.

The statistic stating that the commercial weight loss programs segment is projected to hold a market share of 20.3% by 2027 indicates the anticipated percentage of the total weight loss programs market that will be dominated by commercial programs specifically aimed at helping individuals lose weight. This projection suggests that commercial weight loss programs are expected to be a significant player in the weight loss industry, capturing a sizable portion of consumer demand for such services in the coming years. Factors contributing to this strong forecast could include increasing awareness of weight management, changing lifestyle preferences, and the effectiveness of commercial weight loss programs in meeting consumer needs. This statistic serves as a valuable insight for industry stakeholders, businesses, and investors looking to understand market trends and opportunities within the weight loss industry.

Anti-obesity drugs are expected to reach $2.8 billion by 2022 in the U.S.

This statistic indicates that the market for anti-obesity drugs in the United States is projected to grow significantly, reaching a value of $2.8 billion by the year 2022. This suggests an increasing demand for pharmaceutical interventions to combat obesity within the U.S. population. Factors driving this growth could include rising obesity rates, increased awareness of the health risks associated with obesity, and advancements in drug development for weight management. The statistic also implies opportunities for pharmaceutical companies operating in this market to capitalize on the growing demand for anti-obesity medications and potentially contribute to addressing the public health issue of obesity in the United States.

The global weight loss and diet management market is predicted to reach $348.1 billion by 2026.

The statistic indicates that the global weight loss and diet management market is projected to grow significantly, with an estimated value of $348.1 billion by the year 2026. This suggests a strong demand for weight loss products, services, and programs as individuals worldwide continue to focus on managing their weight and improving their overall health. The expected growth in the market reflects a growing awareness and interest in weight management, driven by factors such as increasing rates of obesity and a general desire for healthier lifestyles. The substantial market value also highlights the opportunities for businesses operating in the weight loss and diet management industry to cater to this growing demand and provide innovative solutions to support individuals in achieving their weight loss goals.

Europe held approximately 31.34% of the weight loss and weight management diet market share in 2019.

The statistic states that Europe accounted for approximately 31.34% of the weight loss and weight management diet market share in 2019. This means that out of the total market for weight loss and weight management diets worldwide in 2019, Europe contributed around one-third of the market share. This information is important for understanding the regional distribution of market demand for products and services related to weight management. It indicates that Europe is a significant player in the weight loss industry and highlights the potential opportunities and challenges for companies operating in this market region.

The weight loss supplement market is anticipated to grow at a CAGR of 4.9% from 2021 to 2028.

This statistic signifies that the weight loss supplement market is projected to experience a steady growth rate over the period from 2021 to 2028, with a Compound Annual Growth Rate (CAGR) of 4.9%. CAGR is a useful measure that represents the annualized growth rate of an investment over a specified time period, smoothing out fluctuations in the data. In this context, a 4.9% CAGR suggests that the market for weight loss supplements is expected to expand consistently over the next seven years. This growth can be influenced by various factors such as increasing consumer awareness about health and wellness, rising obesity rates, changing lifestyle habits, and advancements in supplement formulations and marketing strategies.

Prescription drugs segment held the largest market share of 74.5% in the weight loss products market in 2020.

The statistic indicates that within the weight loss products market in 2020, the prescription drugs segment accounted for the largest proportion of sales at 74.5%. This suggests that a significant majority of consumers seeking weight loss products opted for prescription drugs over other types of products such as over-the-counter supplements or devices. The dominance of the prescription drugs segment may signify a strong preference for products that are prescribed by healthcare professionals and potentially perceived as more effective or trustworthy for weight management purposes. Additionally, it could also reflect the influence of marketing strategies, medical recommendations, or perceived social norms surrounding weight loss products.

The Asia Pacific weight management market is expected to witness a CAGR of 7.1% from 2021 to 2026.

This statistic indicates that the Asia Pacific weight management market is projected to experience a Compound Annual Growth Rate (CAGR) of 7.1% from 2021 to 2026. This means that the market is expected to grow at an average annual rate of 7.1% over the forecast period. A CAGR provides a measure of the rate of growth of a market over time, offering insight into the potential expansion and development of the weight management industry in the Asia Pacific region. This suggests that there is anticipated increased demand for weight management products and services in the coming years, presenting opportunities for businesses operating within this market to capitalize on this growth trend.

The diet food and drink segment is expected to surge at the fastest CAGR of 8.3% from 2021 to 2028 in the weight loss and weight management market.

This statistic indicates that within the weight loss and weight management market, the diet food and drink segment is projected to experience the highest Compound Annual Growth Rate (CAGR) of 8.3% from 2021 to 2028. This suggests that there is a growing demand for diet-specific food and beverages among consumers seeking to manage their weight. The significant CAGR indicates a strong potential for growth and market expansion in this particular segment, reflecting evolving consumer preferences towards healthier and more tailored dietary choices for weight management purposes in the coming years.

Over 25% of the global adult population was overweight in 2019.

The statistic that over 25% of the global adult population was overweight in 2019 indicates a significant and concerning public health issue. Being overweight is associated with various health risks, including an increased likelihood of developing chronic conditions such as heart disease, diabetes, and certain types of cancers. This statistic suggests a widespread prevalence of weight-related health problems, which can have far-reaching consequences on individuals, healthcare systems, and society as a whole. Efforts to address this issue through public health initiatives, education, and policy interventions are crucial to promote healthy lifestyles and reduce the burden of overweight and obesity on a global scale.

The weight loss and weight management market growth in Latin America will likely have a CAGR of 6.8% from 2020 to 2027.

This statistic indicates that the weight loss and weight management market in Latin America is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6.8% from 2020 to 2027. A CAGR of 6.8% suggests a steady and consistent annual growth rate in the market over the specified period. This growth rate indicates that there is increasing demand and potential for products and services related to weight loss and weight management in Latin America. Factors such as changing lifestyles, increasing awareness about health and wellness, and rising disposable incomes may contribute to this projected growth in the market. Overall, this statistic highlights the promising market opportunities for stakeholders and businesses operating in the weight loss and weight management industry in Latin America.

References

0. – https://www.www.psychologytoday.com

1. – https://www.www.marketdataforecast.com

2. – https://www.www.alliedmarketresearch.com

3. – https://www.www.meticulousresearch.com

4. – https://www.www.statista.com

5. – https://www.www.emergenresearch.com

6. – https://www.www.grandviewresearch.com

7. – https://www.www.fortunebusinessinsights.com

How we write our statistic reports:

We have not conducted any studies ourselves. Our article provides a summary of all the statistics and studies available at the time of writing. We are solely presenting a summary, not expressing our own opinion. We have collected all statistics within our internal database. In some cases, we use Artificial Intelligence for formulating the statistics. The articles are updated regularly.

See our Editorial Process.

Table of Contents

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!